Literature DB >> 6691550

Treatment of epidermoid anal canal cancer.

R J Salmon, J Fenton, B Asselain, G Mathieu, J Girodet, J C Durand, Y Decroix, J P Pilleron, J Rousseau.   

Abstract

Between 1968 and 1979, 183 patients with invasive epidermoid cancer of the anal canal were treated at Institut Curie. There was 156 women, 27 men with a mean age of 67 +/- 11 years (range 40 to 85 years). The initial height of the tumor was less than 4 cm (65 patients), 4 to 6 cm (98 patients), and more than 6 cm (20 patients). All the patients received radiotherapy, either preoperatively or as curative procedure. Twenty-five patients received preoperative radiotherapy, and there was no residual tumor in 9 biopsies obtained at operation. Four local recurrences were observed. One hundred fifty-eight patients received curative radiotherapy, 115 of whom did not undergo operation. Eighty were alive with no evidence of disease and good anal function with a minimum of 3 years follow-up. We observed 15 local recurrences, 4 inguinal recurrences, and 8 visceral metastases. In addition, eight patients initially had such a big tumor that radiotherapy was only a palliative procedure. Forty-three patients required a surgical procedure after this curative radiotherapy. Colostomy (12 patients) or abdominoperineal amputation (25 patients) was required for local recurrence and colostomy was required for necrosis related to radiotherapy. Five year survival was 59 percent. The survival was related to the size of the tumor (p less than 0.0001). The likelihood of retaining normal anal function with local control of the tumor was also closely related to the initial size of the tumor.

Entities:  

Mesh:

Year:  1984        PMID: 6691550     DOI: 10.1016/0002-9610(84)90032-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315.

Authors:  Babu Zachariah; Clement K Gwede; Jennifer James; Jaffer Ajani; Lisa J Chin; David Donath; Seth A Rosenthal; Brent L Kane; Marvin Rotman; Lawrence Berk; Lisa A Kachnic
Journal:  J Natl Cancer Inst       Date:  2010-03-25       Impact factor: 13.506

Review 2.  Treatment of primary epidermoid carcinoma of the anal canal.

Authors:  B J Cummings
Journal:  Int J Colorectal Dis       Date:  1987-06       Impact factor: 2.571

Review 3.  New approach to anal cancer: individualized therapy based on sentinel lymph node biopsy.

Authors:  Paola De Nardi; Michele Carvello; Carlo Staudacher
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

4.  Epidermoid cancers of the anal canal: current treatment.

Authors:  Jennifer Blumetti; Amir L Bastawrous
Journal:  Clin Colon Rectal Surg       Date:  2009-05

5.  Endoanal ultrasonography in the follow-up of anal carcinoma.

Authors:  U Herzog; M Boss; H P Spichtin
Journal:  Surg Endosc       Date:  1994-10       Impact factor: 4.584

6.  Limited value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: a prospective study with long-term follow-up.

Authors:  Johannes S de Jong; Jannet C Beukema; Gooitzen M van Dam; Riemer Slart; Clara Lemstra; Theo Wiggers
Journal:  Ann Surg Oncol       Date:  2010-10       Impact factor: 5.344

7.  Radiation therapy in the conservative management of cancers of the low rectum and anal canal.

Authors:  J Papillon
Journal:  Int J Colorectal Dis       Date:  1986-10       Impact factor: 2.571

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.